09604

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

January 22, 2018 Cover

Volume 96, Issue 4

FDA approvals hit a 20-year high in 2017, with cancer and rare-disease drugs dominating the list of new medicines

Cover image:

Full Article

Volume 96 | Issue 4

« Prev

FDA approvals hit a 20-year high in 2017, with cancer and rare-disease drugs dominating the list of new medicines

1 simple molecule holds the key to keeping a tan year-round

Some researchers think lab-grown rhinoceros and elephant mimics could dampen illegal hunting, but conservationists disagree

Business

Weed scientists brace for a second year of dicamba use

Drifty pesticide caused damage and controversy last year, but new restrictions may help
Business

Peptide makers face threat from biotechnology

How a 1-year-old German start-up could be about to shake up a $1 billion market
Business

Shell buys stake in solar developer Silicon Ranch

Firm is among European oil and gas firms turning to renewables to diversify earnings sources
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime